Dupont Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,266
Closed -$319K 316
2023
Q2
$319K Sell
2,266
-5,127
-69% -$707K 0.02% 334
2023
Q1
$1.05M Buy
7,393
+3,296
+80% +$472K 0.05% 192
2022
Q4
$641K Sell
4,097
-2,837
-41% -$408K 0.03% 481
2022
Q3
$851K Sell
6,934
-3,087
-31% -$407K 0.05% 455
2022
Q2
$1.33M Buy
10,021
+2,790
+39% +$380K 0.06% 342
2022
Q1
$990K Sell
7,231
-537
-7% -$74.8K 0.04% 471
2021
Q4
$1.34M Sell
7,768
-1,030
-12% -$157K 0.05% 409
2021
Q3
$1.28M Buy
8,798
+6,546
+291% +$958K 0.04% 462
2021
Q2
$297K Buy
2,252
+58
+3% +$7.59K 0.01% 1198
2021
Q1
$282K Sell
2,194
-674
-24% -$83.1K 0.01% 1168
2020
Q4
$342K Sell
2,868
-392
-12% -$47.8K 0.01% 993
2020
Q3
$373K Sell
3,260
-41
-1% -$4.84K 0.01% 899
2020
Q2
$376K Sell
3,301
-61
-2% -$6.47K 0.01% 891
2020
Q1
$270K Buy
3,362
+1,012
+43% +$105K 0.01% 908
2019
Q4
$251K Buy
2,350
+609
+35% +$63.5K 0.01% 1121
2019
Q3
$186K Hold
1,741
﹤0.01% 1106
2019
Q2
$177K Hold
1,741
﹤0.01% 1134
2019
Q1
$157K Hold
1,741
﹤0.01% 1102
2018
Q4
$145K Buy
1,741
+539
+45% +$50.5K ﹤0.01% 1100
2018
Q3
$130K Hold
1,202
﹤0.01% 905
2018
Q2
$132K Buy
1,202
+471
+64% +$49.1K ﹤0.01% 922
2018
Q1
$73K Sell
731
-20,456
-97% -$2.1M ﹤0.01% 911
2017
Q4
$2.09M Buy
21,187
+313
+1% +$29.7K 0.05% 345
2017
Q3
$1.96M Hold
20,874
0.04% 372
2017
Q2
$2.32M Buy
20,874
+5,763
+38% +$609K 0.05% 323
2017
Q1
$1.48M Buy
15,111
+3,030
+25% +$289K 0.03% 420
2016
Q4
$1.11M Buy
+12,081
New +$1.04M 0.02% 463

Other funds holding DGX

Dupont Capital Management's DGX Position: Q3 2023 in Review

Dupont Capital Management sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 2,266 shares — an estimated $319K sold.

Dupont Capital Management first reported a position in DGX in Q4 2016 and held it in 27 quarters. The position peaked at $2.32M in Q2 2017. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Dupont Capital Management reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 2,266 Quest Diagnostics shares in Q3 2023, an estimated $319K.
  • Dupont Capital Management first reported a position in Quest Diagnostics in Q4 2016 and held it in 27 quarters.
  • Dupont Capital Management's Quest Diagnostics position peaked at $2.32M in Q2 2017.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.